|
Current issue
Archive
Online First
About the journal
Editorial board
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Special Issues
Instructions for authors
Publication charge
Editorial System
Submit your Manuscript
|
1/2010
vol. 9 abstract:
Original paper
Causes of treatment failure in patients with endometrial cancer treated with postoperative radiotherapy
Michał Spych
,
Leszek Gottwald
,
Emilia Jesień-Lewandowicz
,
Justyna Chałubińska
,
Janusz Sobotkowski
,
Jacek Fijuth
Przegląd Menopauzalny 2010; 1: 32–37
Online publish date: 2010/02/25
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Introduction: The treatment of choice for patients with early clinical stage uterine cancer is surgical inter- vention. In complementary treatment in standard use is radiotherapy (teletherapy and brachytherapy). In case of onset of disease recurrence, salvage treatment frequently proves ineffective, which is connected with a high percent of deaths in this group of patients. The aim was to evaluate the causes of treatment failure in patients with endometrial cancer treated with postoperative radiotherapy. Material and methods: Twenty-eight patients aged between 49 and 84 years were enrolled in the study, in whom for the period from 2002 until 2004 postoperative radiotherapy was applied, and in whom during the period of five years after treatment termination disease recurrence was observed. Results: In the analyzed group of patients the 2- and 4-year disease-free survival (DFS) was 41% and 11% respectively. The 2- and 5-year overall survival (OS) was 67% and 13%. Locoregional failures occurred in 5 (17.7%) patients. Distant metastases were detected in 15 (63.6%) patients. In 8 (28.6%) patients, distant metastases occurred simultaneously with local relapse. Neither of the treatment methods after disease recurrence significantly extended the survival of patients (p = 0.82). Patients’ age was the sole prognostic factor which has a statistically significant impact on DFS. On the other hand an adverse affect on overall survival was demonstrated for the variable of the time of disease recurrence. In the group of patients in whom the recurrence was demonstrated earlier than 6 months after treatment termination the OS was significantly shorter (p = 0.001). Conclusions: Distant metastases are the main cause of failures of patients’ treatment for endometrioid endometrial cancer. Neither of the treatment methods after disease recurrence significantly extended the survival of patients. Shorter time to disease recurrence is a negative prognostic factor with reference to overall survival. keywords:
endometrial cancer, recurrence, causes of failures, disease-free survival, overall survival |